Cansu Özbayer
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects 4
-
- Inflammasome and immune disorders 4
-
- Immune Response and Inflammation 4
-
- Adipokines, Inflammation, and Metabolic Diseases 3
-
- Biochemical effects in animals 3
-
- Diet, Metabolism, and Disease 3
-
- Lipoproteins and Cardiovascular Health 2
-
- Liver Disease and Transplantation 2
In The Last Decade
Cansu Özbayer
39 papers receiving 374 citations
Peers
Comparison fields: 5 of 84
- Complementary and alternative medicine 47
- Pharmacology 48
- Toxicology 11
- Biochemistry 17
- Biochemistry 20
Countries citing papers authored by Cansu Özbayer
This map shows the geographic impact of Cansu Özbayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cansu Özbayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cansu Özbayer more than expected).
Fields of papers citing papers by Cansu Özbayer
This network shows the impact of papers produced by Cansu Özbayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cansu Özbayer. The network helps show where Cansu Özbayer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cansu Özbayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 10 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 3 | |
| 12 | 2021 | 1 | |
| 13 | 2018 | 20 | |
| 14 | 2018 | 13 | |
| 15 | 2018 | 4 | |
| 16 | 2016 | 3 | |
| 17 | 2015 | 20 | |
| 18 | 2014 | 6 | |
| 19 | 2011 | 11 | |
| 20 | 2010 | 10 |
About Cansu Özbayer
Cansu Özbayer is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Endocrine and Autonomic Systems, having authored 42 papers that have together received 377 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (4 papers), Immune Response and Inflammation (4 papers), Inflammatory mediators and NSAID effects (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Biochemical effects in animals (3 papers), Diet, Metabolism, and Disease (3 papers), Lipoproteins and Cardiovascular Health (2 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Complementary and alternative medicine (47 citations), Pharmacology (48 citations) and Toxicology (11 citations). Cansu Özbayer has collaborated with scholars based in Türkiye, Colombia and Cambodia. Frequent co-authors include İrfan Değirmenci, Hülyam Kurt, Hasan Veysi Güneş, Mehmet Cengiz Üstüner, Ertuğrul Çolak, Muzaffer Metintaş, Emre Entok, Hilmi Özden, Dilek Burukoğlu and Fatih Kar.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.